&w=3840&q=100)
Stock Market LIVE Updates: GIFT Nifty signals higher open for India markets; Asian peers climb
Sensex Today | Stock Market LIVE Updates Today, June 9: At 6:40 AM, GIFT Nifty futures were ruling 66 points higher at 25,162 level
Stock Market LIVE Updates Today, Monday, June 9, 2025: Stock markets today will be, largely, influenced by global market trends. However, stock-specific triggers, surge in Covid-19 cases, foreign investors' flows, and IPOs will also guide market sentiment today.
At 6:40 AM, GIFT Nifty futures were ruling 66 points higher at 25,162 level.
The BSE Sensex index ended 747 points, or 0.92 per cent, higher at 82,189, while the Nifty50 closed at 25,003, higher by 252 points or 1.02 per cent.
"Although the Nifty remains in a consolidation phase, the buoyancy in rate-sensitive sectors—particularly the breakout seen in the banking index—has renewed hopes of a trend resumption. A decisive breakout above the 25,200 mark in the Nifty could trigger the next leg of the rally, potentially pushing the index toward the 25,600 level," said Ajit Mishra – SVP, research, Religare Broking.
FIIs/FPIs net bought Indian stocks worth ₹1,009.71 crore on Friday, while DIIs bought shares worth ₹9,342.48 crore.
Global markets today
Asian markets were higher on Monday as investors awaited trade talks between Washington and Beijing later in the day.
Japan's Nikkei 225 climbed 0.95 per cent, and South Korea's Kospi index added 1.73 per cent. Australian markets are closed for a public holiday.
On the data front, Japan's January-March quarter GDP data showed that the economy contracted at a slower pace than initially estimated, with the gross domestic product shrinking at an annualised pace of 0.2 per cent as against the initial estimates of a 0.7-per cent contraction.
Meanwhile, China is scheduled to report its consumer and wholesale inflation readings for May today. A Reuters poll estimate China's consumer prices to have fallen by 0.2 per cent year-on-year, while PPI is expected to have declined by 3.2 per cent from a year earlier.
In the US, major Wall Street indices ended higher last Friday after a better-than-expected non-farm payrolls data eased fears of an economic slowdown. US payrolls climbed 139,000 in May, government data showed -- above the Dow Jones forecast of 125,000.
The Dow Jones Industrial Average popped 1.05 per cent, the S&P 500 also gained 1.03 per cent, and the Nasdaq Composite rallied 1.20 per cent.
In the commodities market, Gold prices slipped more than 1 per cent last Friday amid a stronger-than-expected US jobs report. Spot gold fell 1.1 per cent to $3,316.13 an ounce, while US gold futures settled 0.8 per cent lower at $3,346.60.
IPOs Today
In the IPO market, the allotment of Ganga Bath Fittings IPO will be finalised today. Besides, Sacheerome IPO (SME) will open for subscription today.
Connect with us on WhatsApp
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Economic Times
33 minutes ago
- Economic Times
European shares stable as markets eye Sino-US trade talks
(What's moving Sensex and Nifty Track latest market news, stock tips, Budget 2025, Share Market on Budget 2025 and expert advice, on ETMarkets. Also, is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds .) Subscribe to ET Prime and read the Economic Times ePaper Sensex Today. Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price
&w=3840&q=100)

Business Standard
34 minutes ago
- Business Standard
Glenmark Pharma rises 2% as company to launch blood cancer treatment drug
Glenmark Pharma share price rose 1.7 per cent in trade on Tuesday, June 10, 2025, logging an intraday high at ₹1,626.6 per share on BSE. At 10:30 AM, Glenmark Pharma shares were trading 1.56 per cent higher at ₹1,623.35 per share on the BSE. In comparison, the BSE Sensex was up 0.05 per cent at 82,482.52. The company's market capitalisation stood at ₹45,811.07 crore. Its 52-week high was at ₹1,830.05 per share and 52-week low was at ₹1,176 per share. In the past one year, Glenmark shares have gained 33 per cent as compared to Sensex's rise of around 8 per cent. What is boosting rally in Glenmark Pharma shares? The stock gained after the company announced the upcoming launch of zanubrutinib, under the brand name Brukinsa in India. Brukinsa, developed by global oncology company BeOne Medicines (formerly BeiGene), is an orally available Bruton's tyrosine kinase (BTK) inhibitor designed to treat multiple types of B-cell blood cancers. It is the first and only BTK inhibitor approved in India for five types of B-cell malignancies. According to the filing, Brukinsa has already been approved in more than 70 countries, with clinical efficacy demonstrated through trials such as ALPINE, ASPEN and SEQUOIA. Its entry into the Indian market addresses a critical need for new and effective blood cancer treatments. The drug offers a unique pharmacological profile with high response rates and durable disease control across multiple B-cell malignancies. It allows a flexible dosing schedule—once or twice daily—tailored to patient needs. In the ALPINE trial for relapsed or refractory chronic lymphocytic leukaemia (CLL), Brukinsa showed a lower incidence of serious cardiac side effects compared to ibrutinib, a widely used targeted therapy. Fewer patients discontinued Brukinsa due to heart-related complications. About Glenmark Pharmaceuticals Glenmark Pharmaceuticals is a research-led, global pharmaceutical company, having a presence across Branded, Generics, and OTC segments; with a focus on therapeutic areas of respiratory, dermatology and oncology. The company has 11 world-class manufacturing facilities spread across 4 continents, and operations in over 80 countries. About BeOne Medicines BeOne Medicines, formerly known as BeiGene, is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide.
&w=3840&q=100)

Business Standard
34 minutes ago
- Business Standard
Here's why Jana Small Finance Bank share is buzzing in trade on June 10
Jana Small Finance Bank share price: Jana Small Finance Bank (Jana SFB) share price was buzzing in trade on Tuesday, June 10, 2025, with the stock rising up to 6.38 per cent to hit an intraday high of ₹552.90 per share. At 10:06 AM, Jana SFB share price was trading 2.42 per cent higher at ₹532.30 per share. In comparison, BSE Sensex was trading 0.03 per cent higher at 82,469.38 levels. What sparked a rally in Jana SFB share price today? Jana SFB shares advanced after the lender submitted an application to the Reserve Bank of India (RBI), seeking its approval to convert from a Small Finance Bank to a Universal Bank. In an exchange filing, Jana SFB said, 'We wish to inform you that the Bank has submitted its application to the Reserve Bank of India (RBI) today i.e. June 9, 2025 seeking approval for voluntary transition from a Small Finance Bank to a Universal Bank.' Jana SFB Q4 results Adjusted profit after tax (PAT) zoomed 33 per cent year-on-year (Y-o-Y ) to ₹779 crore in FY25, from ₹587 crore in FY24. The Asset AUM stood at ₹29,545 crore, up 19 per cent Y-o-Y with 70 per cent share of secured assets. Its secured assets grew 40 per cent and unsecured de-growth was 11 per cent for FY25. Its total deposits came in at ₹29,120 crore, up 29 per cent Y-o-Y. On Q4 show, Ajay Kanwal, MD and CEO of Jana Small Finance Bank had said, 'With this year's result, we have met the required conditions of GNPA<3 per cent and NNPA<1 per cent for 2 consecutive years. Thus, we will be applying for a Universal Banking Licence in this quarter. The Bank's performance during FY25 has been tremendous given the challenges in the MFI industry and tight liquidity faced during the year. However, being true to our strategy, we grew our Secured book by 40 per cent Y-o-Y, which is now at 70 per cent of AUM. Our deposits have grown at a solid 29 per cent, significantly over pacing the industry. Given that MFI stress peak has past last year, we are looking forward to a solid year ahead.' About Jana SFB Jana Small Finance Bank, a scheduled commercial bank and the fourth-largest Small Finance Bank in India, brings over 16 years of lending experience and serves more than 12 million customers. Established as a bank in March 2018, it has evolved from its roots as an NBFC-MFI into a digitally driven institution with a nationwide footprint across 23 states and 2 union territories through 802 branches. Today, around 70 per cent of its lending portfolio is secured, primarily backed by mortgages. Jana has built a rapidly expanding retail deposit base, underpinned by strong brand recognition and a focus on customer service. Its leadership team brings an average of 27 years of industry experience, supported by a well-rounded and respected Board.